NewSPACInsider launches AI-powered access to its SPAC databaseLearn more →

Market Intel

10 articles this week

Armada III (AACI) to Combine with Brains Bioceutical in $892M Deal

Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. More

Morning SPAC News Roundup: November 6, 2026

A familiar name was appended to the prospectus of the latest SPAC to file for an IPO as Kartoon Studios (NYSE:KACQ.U) put in its paperwork yesterday. It is to be underwritten by EF Hutton, making it the first SPAC to carry that name since the firm went through high-profile split among its management in November 2024. More